Pharmacokinetics and pharmacodynamics study of rhein treating renal fibrosis based on metabonomics approach

被引:15
作者
Sun, Hao [1 ]
Luo, Guangwen [1 ]
Xiang, Zheng [1 ]
Cai, Xiaojun [1 ]
Chen, Dahui [1 ]
机构
[1] Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou 325035, Peoples R China
基金
中国国家自然科学基金;
关键词
Metabolomics; Pharmacokinetic; Pharmacodynamic; Rhein; Rhubarb; CHRONIC KIDNEY-DISEASE; PERFORMANCE LIQUID-CHROMATOGRAPHY; RHUBARB EXTRACT; INTERSTITIAL FIBROSIS; MASS-SPECTROMETRY; METABOLOMICS; RATS; FAILURE; PLASMA; ANTHRAQUINONES;
D O I
10.1016/j.phymed.2016.10.002
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Background: The selection of effect indicators in the pharmacokinetic/ pharmacodynamic study of complex diseases to describe the relationship between plasma concentration and effect indicators is difficult. Purpose: Three effect indicators of renal fibrosis were successfully determined. The relationship between pharmacokinetics and pharmacodynamics of rhein in rhubarb was elucidated. Study design: The study was a metabolomics analysis of rat plasma and pharmacokinetics/ pharmacodynamics of rhein. Methods: A sensitive and simple ultra performance liquid chromatography-tandem triple quadrupole mass spectrometry (UPLC-MS/MS) method was applied to determine the rhein plasma concentration in the rat model of renal fibrosis and rat sham-operated group after the administration of rhubarb decoction. Then, the ultra performance liquid chromatography-Micromass quadrupole-time of flight mass spectrometry (UPLC-QTOF/MS) metabolomics method was used to screen biomarkers of renal fibrosis in rat plasma. Furthermore, the relationship between the plasma concentration of rhein and the concentration of three biomarkers directly related to renal fibrosis were analyzed. Results: The three screened biomarkers could represent the effect of rhein treatment on renal fibrosis. Increasing the plasma concentration of rhein tended to restore the concentration of the three biomarkers in the model group compared with that in the sham-operated group. Evident differences in the area under the plasma concentration-time curve (AUC) of rhein were also observed under different pathological states. The results provide valuable information for the clinical application of rhubarb. Conclusion: Rhein intervention could recover the physiological balance in living organisms from the pharmacokinetic/ pharmacodynamic levels. New information on the pharmacokinetic/pharmacodynamic study of complex diseases is provided. (C) 2016 Elsevier GmbH. All rights reserved.
引用
收藏
页码:1661 / 1670
页数:10
相关论文
共 40 条
[1]   Association of Dyslipidemia with Renal Outcomes in Chronic Kidney Disease [J].
Chen, Szu-Chia ;
Hung, Chi-Chih ;
Kuo, Mei-Chuan ;
Lee, Jia-Jung ;
Chiu, Yi-Wen ;
Chang, Jer-Ming ;
Hwang, Shang-Jyh ;
Chen, Hung-Chun .
PLOS ONE, 2013, 8 (02)
[2]   Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry [J].
Dunn, Warwick B. ;
Broadhurst, David ;
Begley, Paul ;
Zelena, Eva ;
Francis-McIntyre, Sue ;
Anderson, Nadine ;
Brown, Marie ;
Knowles, Joshau D. ;
Halsall, Antony ;
Haselden, John N. ;
Nicholls, Andrew W. ;
Wilson, Ian D. ;
Kell, Douglas B. ;
Goodacre, Royston .
NATURE PROTOCOLS, 2011, 6 (07) :1060-1083
[3]   A comparative study on the tissue distributions of rhubarb anthraquinones in normal and CCl4-injured rats orally administered rhubarb extract [J].
Fang, Fang ;
Wang, Jia-bo ;
Zhao, Yan-ling ;
Jin, Cheng ;
Kong, Wei-jun ;
Zhao, Hai-ping ;
Wang, Hong-juan ;
Xiao, Xiao-he .
JOURNAL OF ETHNOPHARMACOLOGY, 2011, 137 (03) :1492-1497
[4]   Role of Oxidative Stress and Indoxyl Sulfate in Progression of Cardiovascular Disease in Chronic Kidney Disease [J].
Fujii, Hideki ;
Nakai, Kentaro ;
Fukagawa, Masafumi .
THERAPEUTIC APHERESIS AND DIALYSIS, 2011, 15 (02) :125-128
[5]   Rhein Improves Renal Lesion and Ameliorates Dyslipidemia in db/db Mice with Diabetic Nephropathy [J].
Gao, Qing ;
Qin, Wei-Song ;
Jia, Zhong-Hui ;
Zheng, Jing-Min ;
Zeng, Cai-Hong ;
Li, Lei-Shi ;
Liu, Zhi-Hong .
PLANTA MEDICA, 2010, 76 (01) :27-33
[6]   Levels of cholesteryl esters and other lipids in the plasma of patients with end-stage renal failure [J].
Gillett, MPT ;
Obineche, EN ;
Lakhani, MS ;
Abdulle, AM ;
Amirlak, I ;
Al Rukhaimi, M ;
Suleiman, MN .
ANNALS OF SAUDI MEDICINE, 2001, 21 (5-6) :283-286
[7]  
Guo XH, 2001, ACTA PHARMACOL SIN, V22, P934
[8]   Preventive Effects and Mechanisms of Rhein on Renal Interstitial Fibrosis in Obstructive Nephropathy [J].
He, Dongyuan ;
Lee, Li ;
Yang, Junwei ;
Wang, Xiaoyun .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2011, 34 (08) :1219-1226
[9]   Influence of Caffeine on the Sedative Effects of Promethazine Based on Pharmacokinetics and Metabolomics [J].
Huang Min ;
Gao Jian-Yi ;
Zhai Zhi-Gang ;
Liang Qiong-Lin ;
Wang Yi-Ming ;
Bai Yan-Qiang ;
Luo Guo-An .
CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2013, 34 (04) :829-836
[10]   A Pharmacometabonomic Approach To Predicting Metabolic Phenotypes and Pharmacokinetic Parameters of Atorvastatin in Healthy Volunteers [J].
Huang, Qing ;
Aa, Jiye ;
Jia, Huning ;
Xin, Xiaoqing ;
Tao, Chunlei ;
Liu, Linsheng ;
Zou, Bingjie ;
Song, Qinxin ;
Shi, Jian ;
Cao, Bei ;
Yong, Yonghong ;
Wang, Guangji ;
Zhou, Guohua .
JOURNAL OF PROTEOME RESEARCH, 2015, 14 (09) :3970-3981